Skip to main navigation Skip to search Skip to main content

Phase II trial of a survivin vaccine (SurVaxM) for newly diagnosed glioblastoma

Research output: Contribution to conference › Presentation

Original languageAmerican English
StatePublished - Nov 2018
EventSociety for NeuroOncology Annual Meeting -
Duration: Nov 1 2018 → …

Conference

ConferenceSociety for NeuroOncology Annual Meeting
Period11/1/18 → …

Disciplines

  • Medicine and Health Sciences

Cite this